Benjamin Looker, Chief Legal Officer at Esperion Therapeutics, Inc. (ESPR), sold 11,824 shares at $3.15 ($37K) on 2026-06-17, disclosed to the SEC on 2026-06-18.
Open-market sale of $37k ESPR by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | SELL | 2025-12-18 | $24K | — | Filing → |
| ESPR | SELL | 2025-10-20 | $3K | — | Filing → |
| ESPR | SELL | 2025-09-18 | $18K | — | Filing → |